This track will explore the latest advancements in the treatment and prevention of tuberculosis, focusing on novel therapeutic approaches and vaccine development. Researchers are encouraged to present findings that highlight effective strategies for combating TB in various populations.

This session will examine the current epidemiological trends related to lung health, emphasizing the prevalence and risk factors associated with lung diseases. Participants will discuss data-driven insights that inform public health strategies and interventions.

This track will address the complex interplay between lung diseases and comorbid conditions, such as cardiovascular diseases and diabetes. Presentations will focus on the implications of these comorbidities for patient management and treatment outcomes.

This session will delve into effective smoking cessation strategies and their impact on lung health. Researchers will share evidence-based practices and interventions that support individuals in quitting smoking and improving respiratory outcomes.

This track will explore factors influencing patient adherence to treatment regimens for lung diseases, including tuberculosis and COPD. Presentations will highlight innovative approaches to enhance adherence and improve patient outcomes.

This session will focus on the pathophysiology, diagnosis, and management of COPD and bronchiectasis. Researchers are invited to present clinical studies and case reports that contribute to a better understanding of these chronic conditions.

This track will address the challenges and advancements in the management of multidrug-resistant tuberculosis. Discussions will include novel treatment regimens, public health implications, and strategies for controlling MDR TB outbreaks.

This session will investigate the relationship between sleep disorders and lung health, particularly in patients with respiratory conditions. Researchers will present findings on how sleep disturbances affect disease progression and management.

This track will highlight recent innovations in laboratory medicine that enhance the diagnosis and monitoring of lung diseases. Presentations will focus on novel biomarkers, diagnostic techniques, and their clinical applications.

This session will explore best practices in inhaler techniques and the role of oxygen therapy in managing lung diseases. Participants will discuss educational interventions aimed at improving patient competency and therapeutic outcomes.

This track will focus on the importance of spirometry in the assessment and management of lung diseases. Researchers are encouraged to present studies that evaluate the efficacy of spirometry in clinical practice and its role in early diagnosis.